EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

FBXO6 ubiquitinates MAOA to promote monoamine neurotransmitter accumulation and tumor growth in HCC

Chunming Li, Yujun Zhang, Xiao-Tong Lin, Jie Zhang, Lei-Da Zhang, Jianping Gong, Chuan-Ming Xie iD

Journal of Molecular Cell Biology · 17.08.2026

DOI: 10.1093/jmcb/mjag029 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Cell Biology, online erschienen am 17.08.2026. Verfasst von Chunming Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monoamine neurotransmitters dopamine and 5-hydroxytryptamine (serotonin, 5-HT), traditionally implicated in the central nervous system, are increasingly recognized as contributors to hepatocellular carcinoma (HCC). However, the underlying molecular mechanisms remain unclear. Here, we demonstrate that the E3 ubiquitin ligase F-box-only protein 6 (FBXO6) is highly expressed in HCC patients. FBXO6 promotes accumulation of 5-HT and dopamine in HCC by mediating K48-linked ubiquitination and degradation of monoamine oxidase A (MAOA). Elevated monoamine levels activate their cognate receptors, triggering the PI3K/AKT/mTOR signaling axis. Simultaneously, these neurotransmitters induce transglutaminase 2 (TGM2)-dependent histone monoaminylation (H3Q5ser and H3Q5dop), forming a synergistic oncogenic circuit that drives HCC development. Clinical specimens reveal a strong inverse correlation between FBXO6 and MAOA protein levels, validating this regulatory axis. Preclinical studies demonstrate that combined treatment with the mTOR inhibitor everolimus and the TGM2 inhibitor GK921 exerts synergistic antitumor effects against FBXO6-driven HCC, providing a rational therapeutic strategy for patients with FBXO6 overexpression.

Schlagwörter

Stichwörter der Autor:innen

5-HTFBXO6HCCMAOAPI3K/AKT/mTORdopaminemonoaminylation

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Chongqing Medical University, Chongqing 400010, China.
  • Key Laboratory of Hepatobiliary and Pancreatic Surgery, Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing 400038, China.

ORCID-Profile: Chuan-Ming Xie

Zitieren

APA

Li, C., Zhang, Y., Lin, X. T., Zhang, J., Zhang, L. D., Gong, J., & Xie, C. M. (2026). FBXO6 ubiquitinates MAOA to promote monoamine neurotransmitter accumulation and tumor growth in HCC. Journal of Molecular Cell Biology. https://doi.org/10.1093/jmcb/mjag029

Vancouver

Li C, Zhang Y, Lin XT, Zhang J, Zhang LD, Gong J, et al. FBXO6 ubiquitinates MAOA to promote monoamine neurotransmitter accumulation and tumor growth in HCC. Journal of Molecular Cell Biology. 2026. doi:10.1093/jmcb/mjag029

BibTeX
@article{Li2026,
  author = {Li, Chunming and Zhang, Yujun and Lin, Xiao-Tong and Zhang, Jie and Zhang, Lei-Da and Gong, Jianping and Xie, Chuan-Ming},
  title = {FBXO6 ubiquitinates MAOA to promote monoamine neurotransmitter accumulation and tumor growth in HCC},
  journal = {Journal of Molecular Cell Biology},
  year = {2026},
  doi = {10.1093/jmcb/mjag029}
}
Kostenlos starten →